Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates-Reference-Cited by-同舟云学术

Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates

Published:2003-08 Issue:16 Volume:13 Page:2799-2803
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Levin J.I.,Chen J.M.,Cheung K.,Cole D.,Crago C.,Santos E.Delos,Du X.,Khafizova G.,MacEwan G.,Niu C.,Salaski E.J.,Zask A.,Cummons T.,Sung A.,Xu J.,Zhang Y.,Xu W.,Ayral-Kaloustian S.,Jin G.,Cowling R.,Barone D.,Mohler K.M.,Black R.A.,Skotnicki J.S.

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference24 articles.

1. Therapeutic Potential and Strategies for Inhibiting Tumor Necrosis Factor-α

2. Human tumor necrosis factor. Production, purification, and characterization.

3. TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic Target

4. Tumor Necrosis Factor: Function, Release and Clearance

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computer Aided Drug Design;Computer Aided Pharmaceutics and Drug Delivery;2022

2. Structural exploration of arylsulfonamide-based ADAM17 inhibitors through validated comparative multi-QSAR modelling studies;Journal of Molecular Structure;2019-06

3. Targeting Metalloenzymes for Therapeutic Intervention;Chemical Reviews;2018-09-07

4. Hydroxamates;Privileged Structures in Drug Discovery;2018-03-09

5. Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis;Bioorganic & Medicinal Chemistry;2018-02